New hope to stop Leukemia's return after transplant
Disease control
Recruiting now
This study is testing if a new drug called mocravimod can help prevent acute myeloid leukemia (AML) from returning in adults who have received a stem cell transplant. Researchers will compare mocravimod to a placebo (inactive substance) to see if it helps patients live longer wit…
Phase: PHASE3 • Sponsor: Priothera SAS • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC